VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $408,063 | -14.1% | 15,164 | -3.9% | 0.03% | -17.1% |
| Q2 2023 | $475,090 | -6.3% | 15,778 | +0.7% | 0.04% | -12.8% |
| Q1 2023 | $506,778 | +46.2% | 15,665 | +29.5% | 0.05% | +34.3% |
| Q4 2022 | $346,653 | -30.0% | 12,095 | -41.2% | 0.04% | +25.0% |
| Q3 2022 | $495,000 | +38.3% | 20,571 | +57.5% | 0.03% | +33.3% |
| Q2 2022 | $358,000 | -32.8% | 13,061 | -6.1% | 0.02% | -19.2% |
| Q1 2022 | $533,000 | +142.3% | 13,915 | +112.4% | 0.03% | +13.0% |
| Q2 2021 | $220,000 | -36.8% | 6,552 | -26.2% | 0.02% | -59.6% |
| Q3 2020 | $348,000 | +15.6% | 8,883 | +8.2% | 0.06% | +3.6% |
| Q2 2020 | $301,000 | -65.2% | 8,208 | -78.1% | 0.06% | -72.2% |
| Q1 2020 | $864,000 | -31.4% | 37,433 | -13.0% | 0.20% | +3.7% |
| Q4 2019 | $1,260,000 | -38.2% | 43,034 | -43.7% | 0.19% | -55.0% |
| Q3 2019 | $2,038,000 | +57.0% | 76,399 | +50.6% | 0.42% | +149.4% |
| Q2 2019 | $1,298,000 | – | 50,720 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |